![Stéphane Pion](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stéphane Pion
Direktor/Vorstandsmitglied bei PainCeptor Pharma Corp.
Profil
Dr. Pion holds a Ph.D.
degree in Immunology from the Université de Montréal, having conducted his doctorate studies at the Maisonneuve-Rosemont Hospital.
He joined T2C2/Bio in 1998 and is very active in the domain of information technology.
Aktive Positionen von Stéphane Pion
Unternehmen | Position | Beginn |
---|---|---|
PainCeptor Pharma Corp.
![]() PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Stéphane Pion
Unternehmen | Position | Ende |
---|---|---|
Transfer Technologies Commercialisation Capital
![]() Transfer Technologies Commercialisation Capital Investment ManagersFinance T²C² (Transfer Technologies Commercialisation Capital) is a Montréal-based venture capital partnership. They were founded in 1997. | Private-Equity-Analyst | - |
Ausbildung von Stéphane Pion
University of Montréal | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Transfer Technologies Commercialisation Capital
![]() Transfer Technologies Commercialisation Capital Investment ManagersFinance T²C² (Transfer Technologies Commercialisation Capital) is a Montréal-based venture capital partnership. They were founded in 1997. | Finance |
PainCeptor Pharma Corp.
![]() PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Health Technology |